8
Oct
2024

Batavia Biosciences

Exhibitor at CPHI Milan 2024 stand 3D107, BioProduction
About Us

Batavia Biosciences significantly contributes to ease human suffering from infectious diseases and cancer by leveraging our innovative technologies and in-depth know-how at all stages of the development trajectory, from the transition into early clinical studies, to navigating late-stage clinical development and entering commercial manufacturing at higher speed, reduced costs, and with increased success. The company operates state-of-the-art development and manufacturing facilities in Europe and the US 

  • NL
  • 2019
    On CPHI since
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 3D107, BioProduction

Products Featured at CPHI Milan 2024

  • HIP-Vax

    Product HIP-Vax

    The demand for viral vector-based products is growing rapidly. However, there are still manufacturing challenges which hamper the development of these promising new therapies. A major problem is low product yields. For many medical applications, a certain minimal dose of product is needed to have a clinica...